Journal
JOURNAL OF NEUROCHEMISTRY
Volume 82, Issue 4, Pages 1003-1006Publisher
WILEY
DOI: 10.1046/j.1471-4159.2002.01064.x
Keywords
Alzheimer; amyloid; cyclooxygenase; levuglandin; oligomer
Categories
Funding
- NIA NIH HHS [AG16835, AG05144] Funding Source: Medline
- NIGMS NIH HHS [GM15431, GM58008] Funding Source: Medline
Ask authors/readers for more resources
Epidemiologic evidence implicates cyclooxygenase activity in the pathogenesis of Alzheimer's disease, in which amyloid plaques have been found to contain increased levels of dimers and higher multimers of the amyloid beta peptide. The product of the oxygenation of arachidonic acid by the cyclooxygenases, prostaglandin H-2 (PGH(2) ), rearranges non-enzymatically to several prostaglandins, including the highly reactive gamma-keto aldehydes, levuglandins E-2 and D-2 . We demonstrate that PGH(2) markedly accelerates the formation of dimers and higher oligomers of amyloid beta(1-42) . This is associated with the formation of levuglandin adducts of the peptide. These findings provide the molecular basis for a hypothesis linking cyclooxygenase activity to the formation of oligomers of amyloid beta.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available